Search results
Showing 8326 to 8340 of 9024 results
Deucravacitinib for treating active psoriatic arthritis [ID6561]
In development Reference number: GID-TA11510 Expected publication date: TBC
In development Reference number: GID-TA11767 Expected publication date: 04 November 2026
L-Dex U400 for lymphoedema after breast cancer treatment (MIB111)
April 2026: This Medtech innovation briefing has been withdrawn because the L-Dex U400 device is no longer available in the UK.
In development Reference number: GID-TA10960 Expected publication date: TBC
In development Reference number: GID-TA11627 Expected publication date: TBC
Sacituzumab govitecan for treating unresectable metastatic urothelial cancer [ID6150]
Discontinued Reference number: GID-TA11009
Discontinued Reference number: GID-TA10668
Vimseltinib for treating tenosynovial giant cell tumours when surgery is unsuitable [TSID12099]
In development Reference number: GID-TA11640 Expected publication date: TBC
In development Reference number: GID-TA11679 Expected publication date: TBC
Discontinued Reference number: GID-TA10910
Rocatinlimab for treating moderate to severe atopic dermatitis in people 12 years and over [ID6565]
In development Reference number: GID-TA11759 Expected publication date: TBC
Digital technologies for multidisciplinary weight management
In development Reference number: GID-HTE10077 Expected publication date: TBC
Etripamil for treating paroxysmal supraventricular tachycardia [ID6581]
In development Reference number: GID-TA11750 Expected publication date: TBC
Mavacamten for treating symptomatic non-obstructive hypertrophic cardiomyopathy [ID6523]
In development Reference number: GID-TA11664 Expected publication date: TBC
Venglustat for treating gangliosidoses in people 2 years and over [ID6358]
Discontinued Reference number: GID-TA11396